Annual Science Day Event to Address Vaccine Development

June 15, 2011

GlycoVaxyn AG, a developer of conjugate vaccines, will be hosting the Second Annual Science Day to discuss specific challenges and opportunities in vaccine development.  The event will take place on June 16-17, 2011 in Cannes, France.

“A number of serious bacterial diseases still lack vaccines while antibiotic resistance is growing and the costs for vaccines development is increasing,” said Philippe Dro, CEO of GlycoVaxyn. “Setbacks in vaccine development, most recently with Staphylococcus aureus, highlight the challenges facing the vaccine industry and public health professionals. Our science day provides a forum for industry, regulatory and academic thought leaders to address today’s challenges and discuss solutions and recent developments in vaccines. This is our second annual science day, following a very successful event last year.”

Topics for the event include:

  • How and why Johnson & Johnson went into vaccines
  • GlycoVaxyn: Recent achievements in glycoconjugates
  • Regulatory approach for glycoconjugate vaccines
  • Meningococcal vaccines
  • Staphylococcal vaccines


News Release, GlycoVaxyn to Host Second Annual Science Day to Discuss Challenges and Opportunities in Vaccine Development.  PR Newswire.

Second Annual Science Day, Agenda.

Leave a Comment

Previous post:

Next post: